Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This clinical trial will be performed in previously untreated patients with metastatic
colorectal cancer. The study will evaluate the safety, tolerability and efficacy of the study
drug, CT-011, in combination with FOLFOX chemotherapy (FOLFOX4 or mFOLFOX6) compared with
treatment by FOLFOX alone.